Wenshan He

1.8k total citations
40 papers, 1.5k citations indexed

About

Wenshan He is a scholar working on Molecular Biology, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Wenshan He has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Biomedical Engineering and 11 papers in Cancer Research. Recurrent topics in Wenshan He's work include Nanoplatforms for cancer theranostics (9 papers), Electrochemical sensors and biosensors (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Wenshan He is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Electrochemical sensors and biosensors (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Wenshan He collaborates with scholars based in China, Singapore and Hong Kong. Wenshan He's co-authors include Jinghua Ren, Hongwei Duan, Zhe Yang, Yimin Sun, Fei Xiao, Cuiwei Liu, Zhilan Ye, Yan Zhang, Li Zhang and Tao Zhang and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Wenshan He

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenshan He China 21 752 503 326 299 283 40 1.5k
Yue Yang China 20 846 1.1× 524 1.0× 247 0.8× 198 0.7× 119 0.4× 57 1.5k
Chang-Bai Liu China 23 642 0.9× 344 0.7× 144 0.4× 467 1.6× 59 0.2× 53 1.4k
Zheng Huang China 26 1.0k 1.3× 717 1.4× 458 1.4× 183 0.6× 266 0.9× 90 2.1k
Yujuan Zhang China 21 433 0.6× 521 1.0× 212 0.7× 153 0.5× 148 0.5× 62 1.3k
Kouji Iida Japan 27 1.4k 1.8× 122 0.2× 274 0.8× 213 0.7× 400 1.4× 112 2.6k
Weiwei Chen China 13 857 1.1× 547 1.1× 223 0.7× 263 0.9× 212 0.7× 31 1.3k
Pablo Scodeller Estonia 20 699 0.9× 383 0.8× 116 0.4× 163 0.5× 77 0.3× 32 1.5k
Haibin Shi China 25 758 1.0× 1.3k 2.6× 657 2.0× 118 0.4× 128 0.5× 76 2.2k
Shiyun Bao China 17 903 1.2× 927 1.8× 700 2.1× 170 0.6× 518 1.8× 31 2.2k
Francesca Pagliari Italy 18 387 0.5× 490 1.0× 489 1.5× 245 0.8× 163 0.6× 40 1.7k

Countries citing papers authored by Wenshan He

Since Specialization
Citations

This map shows the geographic impact of Wenshan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenshan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenshan He more than expected).

Fields of papers citing papers by Wenshan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenshan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenshan He. The network helps show where Wenshan He may publish in the future.

Co-authorship network of co-authors of Wenshan He

This figure shows the co-authorship network connecting the top 25 collaborators of Wenshan He. A scholar is included among the top collaborators of Wenshan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenshan He. Wenshan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Xin, Jingqu Chen, Wei Fu, et al.. (2025). Peptide Coacervates with Metal–Phenolic Membranes Modulate Glucose Metabolism and Enhance Cancer Immunotherapy. Advanced Materials. 37(47). e10936–e10936.
2.
Liang, Qing, Jiayuan Chen, Shuai Hou, et al.. (2023). Activatable Mn2+-Armed nanoagonist augments antitumor immunity in colorectal cancer: A NIR-II Photonic neoadjuvant paradigm. Biomaterials. 300. 122206–122206. 14 indexed citations
3.
Li, Ruiqi, Lian Chen, Qing Liang, et al.. (2023). Macrophage Membrane‐Coated Nanoparticles Sensitize Glioblastoma to Radiation by Suppressing Proneural–Mesenchymal Transformation in Glioma Stem Cells. Advanced Functional Materials. 33(37). 18 indexed citations
5.
Zhang, Li, Zhe Yang, Wenshan He, Jinghua Ren, & Chun‐Yuen Wong. (2021). One-pot synthesis of a self-reinforcing cascade bioreactor for combined photodynamic/chemodynamic/starvation therapy. Journal of Colloid and Interface Science. 599. 543–555. 65 indexed citations
6.
Yu, Li, et al.. (2021). Extracellular Vesicles as Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis. Frontiers in Cell and Developmental Biology. 9. 754630–754630. 18 indexed citations
7.
Zhao, Jun, Xu Zhang, Ting Guan, et al.. (2019). The association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females. Scientific Reports. 9(1). 3865–3865. 4 indexed citations
8.
Yang, Zhe, Wenshan He, Jielin Wei, et al.. (2018). One-pot synthesis of albumin-gadolinium stabilized polypyrrole nanotheranostic agent for magnetic resonance imaging guided photothermal therapy. Biomaterials. 161. 1–10. 66 indexed citations
10.
12.
Wang, Rui, Wenshan He, Zhi Li, et al.. (2014). Caveolin-1 functions as a key regulator of 17β-estradiol-mediated autophagy and apoptosis in BT474 breast cancer cells. International Journal of Molecular Medicine. 34(3). 822–827. 34 indexed citations
13.
Ren, Jinghua, Min Jin, Wenshan He, et al.. (2013). Association between CHRNA3 rs1051730 genotype and lung cancer risk in Chinese Han population: A case-control study. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(6). 897–901. 8 indexed citations
14.
He, Wenshan, et al.. (2011). The Ku70 −1310C/G promoter polymorphism is associated with breast cancer susceptibility in Chinese Han population. Molecular Biology Reports. 39(1). 577–583. 11 indexed citations
15.
Ren, Jinghua, Wenshan He, Guoli Yan, et al.. (2011). EGFR mutations in non‐small‐cell lung cancer among smokers and non‐smokers: A meta‐analysis. Environmental and Molecular Mutagenesis. 53(1). 78–82. 35 indexed citations
16.
Ren, Jinghua, Wenshan He, Ruiguang Zhang, et al.. (2010). Acquired Cisplatin Resistance in Human Lung Adenocarcinoma Cells Is Associated with Enhanced Autophagy. Cancer Biotherapy and Radiopharmaceuticals. 25(1). 75–80. 108 indexed citations
17.
Ren, Jinghua, et al.. (2010). Lysyl Oxidase 473 G>A Polymorphism and Breast Cancer Susceptibility in Chinese Han Population. DNA and Cell Biology. 30(2). 111–116. 22 indexed citations
18.
Ren, Jinghua, Wenshan He, Ruiguang Zhang, et al.. (2009). RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum α-fetoprotein level. Journal of Huazhong University of Science and Technology [Medical Sciences]. 29(3). 309–312. 11 indexed citations
19.
Li, Zhi, Haiping Song, Wenshan He, Yuan Tian, & Tao Huang. (2008). In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(6). 683–687. 3 indexed citations
20.
He, Wenshan, Tao Huang, & Haijiu Wang. (2006). Expression of cyclin E and its relationship with the prognosis of patients with breast cancer. The Chinese-German Journal of Clinical Oncology. 5(4). 275–278. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026